Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
Condition(s) studied
Study summary
Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.
Eligibility
Primary outcome measure(s)
- Frequency of personalized treatment initiation — At 1 year from date of study inclusion
Frequency of personalized treatment initiation - Frequency of molecularly stratified treatment options — At 1 year from date of study inclusion
Number of molecularly stratified treatment options per patient
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Charité Comprehensive Cancer Center | Berlin | Germany | Recruiting |
More Charite University, Berlin, Germany trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05926284 on ClinicalTrials.gov ↗ ← All trials in Germany